GlassScriptPhysician profile
David J Kim
NPI 1205194560
$15,637.93
in general payments reported to CMS, 2019-2025
44 companies · $2,882 in 2025
The $2,882 reported for 2025 was more than what 84% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,101 · 2020: $1,315 · 2021: $1,495 · 2022: $2,134 · 2023: $2,984 · 2024: $1,728 · 2025: $2,882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,593.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,354.04 | 2019-2025 | Proclaim, Octrode |
| Boston Scientific Corporation | $3,044.01 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Na |
| Nevro Corp. | $2,609.78 | 2019-2024 | Senza |
| Medtronic, INC. | $1,497.61 | 2021-2025 | Inceptiv, Synchromedii, Intellis Adaptivestim |
| Globus Medical, INC. | $1,297.32 | 2025 | Senza, Omnia |
| Painteq LLC | $623.39 | 2022-2023 | Painteq |
| Abbvie INC. | $370.59 | 2022-2025 | |
| Gilead Sciences, INC. | $282.54 | 2019-2021 | |
| Spinal Simplicity, LLC | $225.90 | 2023-2025 | Ha Minuteman G3-R |
| Biodelivery Sciences International, INC. | $212.20 | 2019-2021 | |
| Amgen INC. | $206.17 | 2019-2022 | |
| Mdd US Operations, LLC | $193.17 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $180.59 | 2021 | |
| Spr Therapeutics, INC | $142.54 | 2019-2025 | Sprint Pns System |
| Novartis Pharmaceuticals Corporation | $126.46 | 2019-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.